BOLT: Bolt Biotherapeutics, Inc. Common Stock Company Profile & Statistics

Bolt Biotherapeutics, Inc. Common Stock Profile

About

Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company's principal product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood city, California.

Info & Links

CEO

William P. Quinn

Headquarters

900 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

Bolt Biotherapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

10.20M

Enterprise Value

21.44M

Enterprise Value/EBITDA(ttm)

-0.40

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.04

Price to Book(mrq)

0.26

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

Profit Margin(ttm)

-677.01%

Return on Equity(ttm)

-91.67%

Return on Invested Capital(ttm)

-67.38%

Return on Assets(ttm)

-53.19%

Income Statement

Revenue(ttm)

4.17M

Revenue Per Share(ttm)

2.17

Gross Profit(ttm)

4.17M

EBITDA(ttm)³

-54.24M

Net Income Available to Common(ttm)

-50.71M

Diluted EPS(ttm)

-26.66

Share Statistics

Beta (5Y Monthly)

0.91

52-Week Change

-58.60%

S&P 500 52-Week Change

17.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

1.92M

Dividend Yield

0.00%

Float⁴

1.80M

% Held by Insiders

6.10%

% Held by Institutions

86.70%

Balance Sheet

Total Cash(mrq)

35.55M

Total Cash Per Share(mrq)

18.52

Total Debt(mrq)

21.62M

Total Debt/Equity(mrq)

55.67%

Current Ratio(mrq)

3.11%

Quick Ratio(mrq)

3.11%

Book Value Per Share(mrq)

20.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-11.97

Free Cash Flow(ytd)

-22.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BOLT

Bolt Biotherapeutics, Inc. Common Stock